These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11771952)

  • 1. Accumulation of(125)iodine labeled interleukin-2 in the pancreas of NOD mice.
    Rolandsson O; Stigbrand T; Riklundåhlström K; Eary J; Greenbaum C
    J Autoimmun; 2001 Dec; 17(4):281-7. PubMed ID: 11771952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
    Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
    Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat.
    Papaccio G; Graziano A; d'Aquino R; De Francesco F; Puca A; Pedullà M
    J Cell Physiol; 2006 Dec; 209(3):1016-20. PubMed ID: 16972262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
    Valorani MG; Hawa MI; Buckley LR; Afeltra A; Cacciapaglia F; Pozzilli P
    Diabetes Metab Res Rev; 2004; 20(5):394-8. PubMed ID: 15343585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labelling of interleukin-2 (IL-2) with 123-iodine with retention of its capacity to bind to activated lymphocytes.
    Signore A; Beverley PC; Parman A; Negri M; Pozzilli P
    Exp Clin Endocrinol; 1987 Aug; 89(3):301-6. PubMed ID: 3499331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.
    Geutskens SB; Homo-Delarche F; Pleau JM; Durant S; Drexhage HA; Savino W
    Cell Tissue Res; 2004 Dec; 318(3):579-89. PubMed ID: 15480796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
    Merani S; Edgar RL; Toso C; Emamaullee J; Thiesen A; Shapiro AM
    Autoimmunity; 2009 Mar; 42(3):242-8. PubMed ID: 19301207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice.
    Bouma G; Coppens JM; Mourits S; Nikolic T; Sozzani S; Drexhage HA; Versnel MA
    Eur J Immunol; 2005 Aug; 35(8):2386-96. PubMed ID: 16047341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of monocyte chemoattractant protein-1 in the pancreas of mice.
    Li D; Zhu SW; Liu DJ; Liu GL; Shan ZY
    Chin Med J (Engl); 2005 Aug; 118(15):1269-73. PubMed ID: 16117880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
    Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK
    J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
    Füchtenbusch M; Larger E; Thebault K; Boitard C
    Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation.
    Bouma G; Nikolic T; Coppens JM; van Helden-Meeuwsen CG; Leenen PJ; Drexhage HA; Sozzani S; Versnel MA
    Eur J Immunol; 2005 Jan; 35(1):225-35. PubMed ID: 15593124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune cells, pancreas development, regeneration and type 1 diabetes.
    Homo-Delarche F; Drexhage HA
    Trends Immunol; 2004 May; 25(5):222-9. PubMed ID: 15099561
    [No Abstract]   [Full Text] [Related]  

  • 17. A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes.
    Beales PE; Elliott RB; Flohé S; Hill JP; Kolb H; Pozzilli P; Wang GS; Wasmuth H; Scott FW
    Diabetologia; 2002 Sep; 45(9):1240-6. PubMed ID: 12242456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
    Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15.
    Rothe H; Hausmann A; Kolb H
    Horm Metab Res; 2002 Jan; 34(1):7-12. PubMed ID: 11832994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2.
    Signore A; Chianelli M; Ferretti E; Toscano A; Britton KE; Andreani D; Gale EA; Pozzilli P
    Eur J Endocrinol; 1994 Oct; 131(4):431-7. PubMed ID: 7921233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.